CCN2 Mediates S1P-Induced Upregulation of COX2 Expression in Human Granulosa-Lutein Cells

Cells. 2019 Nov 15;8(11):1445. doi: 10.3390/cells8111445.

Abstract

CCN1 and CCN2 are members of the CCN family and play essential roles in the regulation of multiple female reproductive functions, including ovulation. Cyclooxygenase-2 (COX2) is a critical mediator of ovulation and can be induced by sphingosine-1-phosphate (S1P) through the S1P1/3-mediated Yes-associated protein (YAP) signaling. However, it is unclear whether CCN1 or CCN2 can mediate S1P-induced upregulation of COX2 expression and increase in prostaglandin E2 (PGE2) production in human granulosa-lutein (hGL) cells. In the present study, we investigated the effects of S1P on the expressions of CCN1 and CCN2 in hGL cells. Additionally, we used a dual inhibition approach (siRNA-mediated silencing and small molecular inhibitors) to investigate the molecular mechanisms of S1P effects. Our results showed that S1P treatment significantly upregulated the expression of CCN1 and CCN2 in a concentration-dependent manner in hGL cells. Additionally, inhibition or silencing of S1P1, but not S1P3, completely abolished the S1P-induced upregulation of CCN2 expression. Furthermore, we demonstrated that S1P-induced nuclear translocation of YAP and inhibition or silencing of YAP completely abolished the S1P-induced upregulation of CCN1 and CCN2 expression. Notably, silencing of CCN2, but not CCN1, completely reversed the S1P-induced upregulation of COX2 expression and the increase in PGE2 production. Thus, CCN2 mediates the S1P-induced upregulation of COX2 expression through the S1P1-mediated signaling pathway in hGL cells. Our findings expand our understanding of the molecular mechanism underlying the S1P-mediated cellular activities in the human ovary.

Keywords: CCN2; COX2; PGE2; S1P; S1P1; human granulosa cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle Proteins / metabolism*
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Connective Tissue Growth Factor / genetics
  • Connective Tissue Growth Factor / metabolism*
  • Cyclooxygenase 2 / metabolism*
  • Cysteine-Rich Protein 61 / genetics
  • Cysteine-Rich Protein 61 / metabolism*
  • Dinoprostone / metabolism
  • Dose-Response Relationship, Drug
  • Female
  • Gene Expression Regulation / drug effects
  • Humans
  • Luteal Cells / cytology*
  • Luteal Cells / drug effects
  • Luteal Cells / metabolism
  • Lysophospholipids / pharmacology*
  • Signal Transduction / drug effects
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology
  • Sphingosine-1-Phosphate Receptors / antagonists & inhibitors
  • Sphingosine-1-Phosphate Receptors / metabolism
  • Transcription Factors / metabolism*
  • Up-Regulation

Substances

  • CCN1 protein, human
  • CCN2 protein, human
  • Cell Cycle Proteins
  • Cysteine-Rich Protein 61
  • Lysophospholipids
  • Sphingosine-1-Phosphate Receptors
  • Transcription Factors
  • YY1AP1 protein, human
  • Connective Tissue Growth Factor
  • sphingosine 1-phosphate
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Dinoprostone
  • Sphingosine

Grants and funding